ADCT Stock-Based Compensation

Adc Therapeutics Sa · Stock-Based Compensation

ADCT logo

ADCT Stock-Based Compensation

Latest reported$15.12M
ADCT TTM Stock-Based Comp ($469.00K → $15.12M)
High-resolution chart · PNG

ADCT stock-based compensation history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Adc Therapeutics Sa Stock-Based Compensation — Trailing twelve months (TTM) (USD)
Period endingStock-Based Compensation (USD)
15,119,000
12,380,000
12,359,000
7,848,000
8,654,000
8,831,000
6,568,000
4,952,000
4,229,000
3,359,000
11,275,000
11,275,000
23,757,000
36,457,000
41,781,000
55,245,000
55,478,000
41,660,000
42,213,000
44,165,000
40,355,000
53,089,000
42,928,000
28,273,000
17,501,000
4,823,000
1,103,000
434,000
310,000
396,500
469,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.